ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1588

Resistance Training in Patients with Psoriatic Arthritis Improves Function, Disease Activity and Quality of Life

Diego Roger Silva1, Fabio Jennings1, Emilia Moreira1 and Jamil Natour2, 1Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 2Internal Medicine, Escola Paulista de Medicina/ Universidade Federal de São Paulo, São Paulo, Brazil

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Physical function and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment II

Session Type: Abstract Submissions (ACR)

Background/Purpose

Psoriatic arthritis (PSA) is a chronic inflammatory arthritis, defined as the association of inflammatory arthropathy and skin psoriasis. The literature is still very scarce with regard to non-pharmacological treatments for patients with PSA, specially physical exercise.

Objective: The aim of this study was to assess the effectiveness of resistance training in improving functional capacity, muscle strength, quality of life and disease activity in patients with PSA. 

Methods

Forty-one patients aged between 18 and 65 years with diagnosis of psoriatic arthritis were selected to this study.,The patients were randomized into two groups: intervention group and control group. The intervention group (IG) underwent resistance exercise twice a week, for twelve weeks. The control group remained on the waiting list with the conventional drug therapy. The outcome measurements were: BASFI and HAQ-S for functional capacity, one maximum-repetition test (! RM) for strength (1RM), SF-36 questionnaire for general quality of life; and BASDAI and DAS-28 for disease activity. The evaluations were done by a blinded evaluator at baseline (T0), 6 weeks (T6) and 12 weeks (T12) after the beginning of the study.

Results

At baseline the groups were homogeneous regarding clinical and demographic characteristics. The IG significantly improved functional capacity measured by HAQ-S and disease activity measured by BASDAI, compared to CG, at week 12. Regarding quality of life, the IG improved the domains “pain” and “general health status” compared to CG. (p <0.05). There was improvement in muscular strength in almost all exercises in IG, except in the exercise for biceps.  In the CG, the improvement in strength was observed only on “crucifix”  (bilateral) and “leg extension” (bilateral) exercises. However, there was statistical differences between groups only on exercise “leg extension” (right side) in favor of IG.

Conclusion

Resistance training is effective in improving physical capacity, disease activity and quality of life of patients with psoriatic arthritis. The clinical improvements were not coupled to significant changes in muscular strength.


Disclosure:

D. R. Silva,
None;

F. Jennings,
None;

E. Moreira,
None;

J. Natour,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/resistance-training-in-patients-with-psoriatic-arthritis-improves-function-disease-activity-and-quality-of-life/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology